Extremophilic Cyanobacteria For Novel Drug Development (eBook)
VII, 92 Seiten
Springer International Publishing (Verlag)
978-3-319-12009-6 (ISBN)
This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs.
Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.
Dr. Jnanendra Rath was awarded a Ph.D. in botany from Utkal University, Bhubaneswar, India, for his research on ecophysiological studies on the algae of Chilika Lake on the east coast of India. He served as an assistant professor in Visva-Bharati University, Santiniketan, India, and started his independent research on bioprospecting of cyanobacteria from extreme habitats. He established the Visva-Bharati Culture Collection of Algae (VBCCA) and is affiliated with the World Federation for Culture Collections (WFCC). His major research interest includes ecophysiology and survival strategies of cyanobacteria in extreme environment as well as obtaining bioactive secondary metabolites from cyanobacteria. He is an alumnus of the United Nations Institute for Training and Research (UNITAR) and a partner of the Expert Center for Taxonomic Identification and the United Nations Educational, Scientific and Cultural Organization (UNESCO). Dr. Rath is also a member of the Society of Wetland Scientists as well as several scientific bodies including the Psychological Society of America, American Association for the Advancement of Science, the Association of Microbiologists of India, and the Indian Psychological Society. He is the recipient of the Raman Fellowship under the Indo-US 21st Century Knowledge Initiative and is currently a visiting scholar in the University of Mississippi School of Pharmacy, Oxford, Mississippi, USA. He has completed three externally funded research projects and has authored two books and twenty-four papers published in internationally recognized journals.
Dr. Sikha Mandal completed her M.Phil. in environmental science and was awarded a Ph.D. in botany from Visva-Bharati University, Santiniketan, India, for her research on extremophilic cyanobacteria of eastern India. She worked as a senior research fellow and research associate in a project sponsored by the Council of Scientific & Industrial Research (CSIR). Her major research interests include drug discovery and bioprospecting of extremophilic cyanobacteria. Dr. Mandal was awarded a Federation of European Microbiological Societies (FEMS) Young Scientist grant and a Society of Wetland Scientists (SWS) Women Scientists award. She is currently a member of SWS and the Psychological Society of America. She has published four papers in internationally reputed journal and is the author of three book chapters.
Dr. Jnanendra Rath was awarded a Ph.D. in botany from Utkal University, Bhubaneswar, India, for his research on ecophysiological studies on the algae of Chilika Lake on the east coast of India. He served as an assistant professor in Visva-Bharati University, Santiniketan, India, and started his independent research on bioprospecting of cyanobacteria from extreme habitats. He established the Visva-Bharati Culture Collection of Algae (VBCCA) and is affiliated with the World Federation for Culture Collections (WFCC). His major research interest includes ecophysiology and survival strategies of cyanobacteria in extreme environment as well as obtaining bioactive secondary metabolites from cyanobacteria. He is an alumnus of the United Nations Institute for Training and Research (UNITAR) and a partner of the Expert Center for Taxonomic Identification and the United Nations Educational, Scientific and Cultural Organization (UNESCO). Dr. Rath is also a member of the Society of Wetland Scientists as well as several scientific bodies including the Psychological Society of America, American Association for the Advancement of Science, the Association of Microbiologists of India, and the Indian Psychological Society. He is the recipient of the Raman Fellowship under the Indo-US 21st Century Knowledge Initiative and is currently a visiting scholar in the University of Mississippi School of Pharmacy, Oxford, Mississippi, USA. He has completed three externally funded research projects and has authored two books and twenty-four papers published in internationally recognized journals.Dr. Sikha Mandal completed her M.Phil. in environmental science and was awarded a Ph.D. in botany from Visva-Bharati University, Santiniketan, India, for her research on extremophilic cyanobacteria of eastern India. She worked as a senior research fellow and research associate in a project sponsored by the Council of Scientific & Industrial Research (CSIR). Her major research interests include drug discovery and bioprospecting of extremophilic cyanobacteria. Dr. Mandal was awarded a Federation of European Microbiological Societies (FEMS) Young Scientist grant and a Society of Wetland Scientists (SWS) Women Scientists award. She is currently a member of SWS and the Psychological Society of America. She has published four papers in internationally reputed journal and is the author of three book chapters.
.- 1 Introduction.- 2 Secondary Metabolites of Cyanobacteria and Drug Development.- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them.- 4 Anticancer Drug Development from Cyanobacteria.- 5 Issues and Challenges of Drug Development from Cyanobacteria.
Erscheint lt. Verlag | 24.11.2014 |
---|---|
Reihe/Serie | SpringerBriefs in Pharmaceutical Science & Drug Development | SpringerBriefs in Pharmaceutical Science & Drug Development |
Zusatzinfo | VII, 92 p. 1 illus. |
Verlagsort | Cham |
Sprache | englisch |
Themenwelt | Naturwissenschaften ► Chemie |
Technik | |
Schlagworte | drug development • extremophilic cyanobacteria • Glycomics • Metabolic Pathways • Metagenomics • secondary metabolites |
ISBN-10 | 3-319-12009-3 / 3319120093 |
ISBN-13 | 978-3-319-12009-6 / 9783319120096 |
Haben Sie eine Frage zum Produkt? |
Größe: 1,0 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich